MX9307409A - Agentes para la preparacion y el tratamiento de los disturbios de la membrana de la mucosa intestinal. - Google Patents
Agentes para la preparacion y el tratamiento de los disturbios de la membrana de la mucosa intestinal.Info
- Publication number
- MX9307409A MX9307409A MX9307409A MX9307409A MX9307409A MX 9307409 A MX9307409 A MX 9307409A MX 9307409 A MX9307409 A MX 9307409A MX 9307409 A MX9307409 A MX 9307409A MX 9307409 A MX9307409 A MX 9307409A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- intestinal mucosa
- disorders
- membrane
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
La presente invención se relaciona con un agente para la prevención y el tratamiento de los disturbios de la membrana de la mucosa intestinal, que comprende, como el ingrediente activo, un derivado del carbostirilo representado por la fórmula general: (en donde, R es átomo de halógeno; el sustituyente sobre el esqueleto del carbostirilo está en la posición 3 o en la posición 4 del esqueleto del carbostirilo; y el enlace entre las posiciones 3 y 4 del esqueleto de carbostirilo es una ligadura simple o una doble ligadura) o una sal del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31685292 | 1992-11-26 | ||
JP5231353A JP2872546B2 (ja) | 1992-11-26 | 1993-09-17 | 腸粘膜障害保護剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9307409A true MX9307409A (es) | 1994-07-29 |
Family
ID=26529821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9307409A MX9307409A (es) | 1992-11-26 | 1993-11-25 | Agentes para la preparacion y el tratamiento de los disturbios de la membrana de la mucosa intestinal. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5576331A (es) |
EP (1) | EP0621782A1 (es) |
JP (1) | JP2872546B2 (es) |
KR (1) | KR0175345B1 (es) |
CN (1) | CN1040176C (es) |
AU (1) | AU668267B2 (es) |
CA (1) | CA2128094A1 (es) |
MX (1) | MX9307409A (es) |
WO (1) | WO1994012182A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0674515T3 (da) * | 1993-10-21 | 1999-12-20 | Otsuka Pharma Co Ltd | Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8 |
JPH0971532A (ja) * | 1995-09-06 | 1997-03-18 | Otsuka Pharmaceut Co Ltd | 発癌抑制剤 |
WO1998026769A1 (en) * | 1996-12-16 | 1998-06-25 | Otsuka Pharmaceutical Co., Ltd. | Adp-ribosyltransferase inhibitor |
JP2010024239A (ja) * | 1998-05-06 | 2010-02-04 | Kowa Co | 消化管運動抑制剤 |
US6821953B1 (en) * | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
CN1859948B (zh) * | 2003-07-30 | 2010-05-26 | 大塚制药株式会社 | 促进唾液分泌的喹诺酮衍生物 |
TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS597168A (ja) * | 1982-07-05 | 1984-01-14 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
JPS60142959A (ja) * | 1983-12-28 | 1985-07-29 | Otsuka Pharmaceut Co Ltd | キノリン誘導体 |
JPH0713138B2 (ja) * | 1986-07-30 | 1995-02-15 | 保土谷化学工業株式会社 | ポリテトラメチレンエ−テルグリコ−ルの製法 |
JPH01308258A (ja) * | 1989-04-27 | 1989-12-12 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
JP2812998B2 (ja) * | 1989-08-14 | 1998-10-22 | 大塚製薬 株式会社 | 胃炎治療剤 |
JP2820739B2 (ja) * | 1989-10-28 | 1998-11-05 | 大塚製薬株式会社 | カルボスチリル誘導体の製造法 |
JPH06335623A (ja) * | 1993-05-28 | 1994-12-06 | Dainippon Ink & Chem Inc | 脱気膜および脱気方法 |
-
1993
- 1993-09-17 JP JP5231353A patent/JP2872546B2/ja not_active Expired - Lifetime
- 1993-11-19 WO PCT/JP1993/001700 patent/WO1994012182A1/en not_active Application Discontinuation
- 1993-11-19 US US08/256,372 patent/US5576331A/en not_active Expired - Fee Related
- 1993-11-19 CA CA002128094A patent/CA2128094A1/en not_active Abandoned
- 1993-11-19 AU AU55340/94A patent/AU668267B2/en not_active Ceased
- 1993-11-19 EP EP94900289A patent/EP0621782A1/en not_active Ceased
- 1993-11-19 KR KR1019940702560A patent/KR0175345B1/ko not_active IP Right Cessation
- 1993-11-25 MX MX9307409A patent/MX9307409A/es not_active IP Right Cessation
- 1993-11-26 CN CN93114962A patent/CN1040176C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR0175345B1 (ko) | 1999-02-18 |
WO1994012182A1 (en) | 1994-06-09 |
AU5534094A (en) | 1994-06-22 |
CN1095593A (zh) | 1994-11-30 |
CA2128094A1 (en) | 1994-06-09 |
KR950700064A (ko) | 1995-01-16 |
CN1040176C (zh) | 1998-10-14 |
US5576331A (en) | 1996-11-19 |
JPH06211662A (ja) | 1994-08-02 |
EP0621782A1 (en) | 1994-11-02 |
AU668267B2 (en) | 1996-04-26 |
JP2872546B2 (ja) | 1999-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2159591T3 (es) | Composicion de liberacion controlada. | |
UY27092A1 (es) | Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen | |
DK0750618T3 (da) | Oxazolidinonderivater og farmaceutiske præparater indeholdende dem | |
KR920019342A (ko) | 골질환 치료제 | |
BR9912098A (pt) | Derivado de tiobenzimidazol, composição farmacêutica, e, agente preventivo e/ou terapêutico | |
AR070051A2 (es) | Una preparacion farmaceutica para la cura del sindrome de xeroftalmia | |
ES2177654T3 (es) | Remedio contra la degeneracion espinocerebelosa. | |
ES2171416T3 (es) | Remedio contra la trombocitopenia. | |
DE69528005T2 (de) | Prolineamid-Derivate | |
EP0444196A4 (en) | Agent for treatment and prophylaxis of ischemic disease of heart or brain | |
DE69327432D1 (de) | Heilmittel für wunden und hämorrhoiden | |
ES2062943B1 (es) | Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas. | |
PA8451801A1 (es) | Derivados de la 9-oxima eritromicina | |
AR011409A1 (es) | Derivados de 16-hidroxi-11-(fenil substituido)-estra-4,9-dieno, su utilizacion, un procedimiento para prepararlos, formulaciones farmaceuticasque comprenden a dichos derivados, y un compuesto utilizable como intermediario para prepararlos | |
AR012504A1 (es) | Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion. | |
BR0013793A (pt) | Medicamentos profiláticos e terapêuticos para doenças oftálmicas | |
MX9307409A (es) | Agentes para la preparacion y el tratamiento de los disturbios de la membrana de la mucosa intestinal. | |
AR014964A1 (es) | Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones | |
CA2438799A1 (en) | Preventative of therapeutic agent for inflammatory respiratory tract disease | |
DK0585722T3 (da) | Benzimidazolderivater som antimikrobielt middel mod Campylobacter pylon | |
BR0210744A (pt) | Combinação farmacêutica sinergìstica para a prevenção ou tratamento de diabetes | |
PT630252E (pt) | Preparacao farmaceutica baseada em ramnolipido contra doencas dermatologicas | |
ES2109752T3 (es) | Medicamento para tratamiento terapeutico y profilactico de enfermedades causadas por hiperplasia de las celulas de los musculos lisos. | |
BRPI0317188A2 (pt) | Novo derivado de 2,4-diamino-1,3,5-triazina | |
ES2118650T3 (es) | Derivados de la quinolina-4-carbonilguanidina, procedimiento para la preparacion de los mismos y preparaciones farmaceuticas que contienen los compuestos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |